Quick Answer
LISATA THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $15.96 million for the year ending 2025.
- LISATA THERAPEUTICS, INC. showed a decrease of -1.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $10.96 million | Q3 2010: $4.07 million | Q4 2010: $15.61 million | Q1 2011: $9.41 million | Q2 2011: $1.98 million | Q3 2011: $10.16 million | Q1 2012: $7.00 million | Q2 2012: $2.11 million | Q3 2012: $5.39 million | Q4 2012: $13.74 million | Q1 2013: $9.25 million | Q2 2013: $14.72 million | Q3 2013: $16.95 million | Q4 2013: $46.13 million | Q1 2014: $41.36 million | Q2 2014: $32.87 million | Q3 2014: $32.14 million | Q4 2014: $19.17 million | Q1 2015: $19.13 million | Q2 2015: $36.21 million | Q3 2015: $24.04 million | Q4 2015: $18.66 million | Q1 2016: $25.43 million | Q2 2016: $10.34 million | Q3 2016: $18.61 million | Q1 2017: $12.00 million | Q2 2017: $23.04 million | Q3 2017: $15.08 million | Q1 2018: $21.60 million | Q2 2018: $22.73 million | Q3 2018: $14.37 million | Q1 2019: $14.42 million | Q2 2019: $11.75 million | Q3 2019: $12.67 million | Q1 2020: $20.75 million | Q2 2020: $26.68 million | Q3 2020: $21.16 million | Q1 2021: $28.74 million | Q2 2021: $12.94 million | Q3 2021: $12.77 million | Q1 2022: $12.75 million | Q2 2022: $33.35 million | Q3 2022: $31.48 million | Q1 2023: $28.16 million | Q2 2023: $23.69 million | Q3 2023: $32.43 million | Q1 2024: $21.81 million | Q2 2024: $28.29 million | Q3 2024: $19.51 million | Q1 2025: $20.22 million | Q2 2025: $16.84 million | Q3 2025: $19.00 million.
- Over the full 18 years of available data (2009 to 2025), LISATA THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 122.9%.
- Historical annual values: Fiscal year 2025: $15.96 million | Fiscal year 2024: $16.21 million | Fiscal year 2023: $22.59 million | Fiscal year 2022: $32.15 million | Fiscal year 2021: $24.65 million | Fiscal year 2020: $16.51 million | Fiscal year 2019: $14.03 million | Fiscal year 2018: $10.30 million | Fiscal year 2017: $29.16 million | Fiscal year 2016: $7.08 million | Fiscal year 2015: $20.32 million | Fiscal year 2014: $19.17 million | Fiscal year 2013: $46.13 million | Fiscal year 2012: $13.74 million | Fiscal year 2012: $12.30 million | Fiscal year 2011: $3.94 million | Fiscal year 2010: $15.61 million | Fiscal year 2009: $7.16 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: